8 Lung Cancer Clinical Trials in Hot Springs, AR (2026)

Q: How do I join a clinical trial in Hot Springs?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hot Springs research site will contact you.

Recruiting Lung Cancer Studies in Hot Springs

NCT05899608Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

This is a Phase 3 Randomized, double-blind, Multiregional Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non...

Hot Springs, ARPHASE31,600 participantsSummit Therapeutics

View Study Details

NCT04267848Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by...

Hot Springs, ARPHASE31,210 participantsNational Cancer Institute (NCI)

View Study Details

NCT06767514Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival....

Hot Springs, ARPHASE3780 participantsSummit Therapeutics

View Study Details

NCT06095583Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

The Study is a Phase 3, randomized, three-arm, double-blind, placebo-controlled, multi-regional clinical research study to evaluate the safety and efficacy use of toripalimab alone or in combination w...

Hot Springs, ARPHASE3756 participantsShanghai Junshi Bioscience Co., Ltd.

View Study Details

NCT06801834Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...

Hot Springs, ARPHASE3695 participantsGilead Sciences

View Study Details

NCT06646276Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab...

Hot Springs, ARPHASE3530 participantsBristol-Myers Squibb

View Study Details

NCT07005128Recruiting

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin and etoposide on prolon...

Hot Springs, ARPHASE3330 participantsAmgen

View Study Details

NCT04181060Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage II...

Hot Springs, ARPHASE3300 participantsNational Cancer Institute (NCI)

View Study Details

About Lung Cancer Clinical Trials in Hot Springs

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 8 lung cancer clinical trials recruiting participants in Hot Springs, AR. These studies are seeking a combined 6,201 participants. Research is being sponsored by Summit Therapeutics, National Cancer Institute (NCI), Shanghai Junshi Bioscience Co., Ltd. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Hot Springs — FAQ

Are there lung cancer clinical trials in Hot Springs?

Yes, there are 8 lung cancer clinical trials currently recruiting in Hot Springs, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hot Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hot Springs research site will contact you about next steps.

Are clinical trials in Hot Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hot Springs studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 8 active trials in Hot Springs are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 22, 2026 from ClinicalTrials.gov